Bayer’s strong first quarter performance was mainly driven by its pharmaceuticals division, even as its crop-science branch lagged.
Trending
- H&M onthult nieuwe collectie met Stella McCartney
- Joe Russo Teases ‘Avengers: Endgame’ Re-Release At Sands
- 'Ceasefire in the Middle East, especially in Lebanon, are meant to be broken', analyst says
- Spain urges EU to scrap Association Agreement with Israel
- Trump’s Strait of Hormuz blockade hits Iran’s oil trade
- Nadia Farès Dead: French Actress Was 57
- Ryan Reynolds on Business Ventures, Blake Lively and ‘Deadpool’
- Google in talks with Marvell to build new AI chips for inference, The Information reports
